EE201 Cost-Effectiveness of Romiplostim for the Treatment of Patients with Early Immune Thrombocytopenia in the Czech Republic
Abstract
Authors
C van Beurden-Tan Z Kucera B Pasztor S Vesela L Cervinek E Konirova T Kozak IM Majer